Top

Current Pain and Headache Reports

Published in:

17-11-2023 | Back Pain | Neuropathic Pain (A Abd-Elsayed, Section Editor)

Roles of Chemokines in Intervertebral Disk Degeneration

Authors: Pengfei Xue, Yi Wang, Long Lv, Dongming Wang, Yuntao Wang

Published in: Current Pain and Headache Reports | Issue 3/2024

Abstract

Purpose of Review

Intervertebral disc degeneration is the primary etiology of low back pain and radicular pain. This review examines the roles of crucial chemokines in different stages of degenerative disc disease, along with interventions targeting chemokine function to mitigate disc degeneration.

Recent Findings

The release of chemokines from degenerated discs facilitates the infiltration and activation of immune cells, thereby intensifying the inflammatory cascade response. The migration of immune cells into the venous lumen is concomitant with the emergence of microvascular tissue and nerve fibers. Furthermore, the presence of neurogenic factors secreted by disc cells and immune cells stimulates the activation of pain-related cation channels in the dorsal root ganglion, potentially exacerbating discogenic and neurogenic pain and intensifying the degenerative cascade response mediated by chemokines.

Summary

Gaining a deeper comprehension of the functions of chemokines and immune cells in these processes involving catabolism, angiogenesis, and injury detection could offer novel therapeutic avenues for managing symptomatic disc disease.

Sandal LF, Bach K, Øverås CK, Svendsen MJ, Dalager T, Jensen JSD, et al. Effectiveness of app-delivered, tailored self-management support for adults with lower back pain-related disability: a selfBACK randomized clinical trial. JAMA Intern Med. 2021;181(10):1288–96.PubMed

Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2019;394(10204):1145–58.PubMed

Wu D, Wong P, Guo C, Tam LS, Gu J. Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the Global Burden of Disease Study 2017. BMC Med. 2021;19(1):34.PubMedPubMedCentral

Kreiner DS, Hwang SW, Easa JE, Resnick DK, Baisden JL, Bess S, et al. An evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy. Spine J. 2014;14(1):180–91.PubMed

Joaquim AF, Botelho RV, Mudo ML, Almeida AS, Bernardo WM. Lumbar herniated disc - endoscopic discectomy treatment. Rev Assoc Med Bras (1992). 2018;64(5):397–407.PubMed

Deyo RA, Mirza SK. Clinical Practice. Herniated lumbar intervertebral disk. N Engl J Med. 2016;374(18):1763–72.PubMed

Weber H. Lumbar disc herniation. A controlled, prospective study with ten years of observation. Spine. 1983;8(2):131–40.PubMed

Zhou QK, Zeng FH, Tu JL, Dong ZQ, Ding ZH. Influence of cement-augmented pedicle screw instrumentation in an osteoporotic lumbosacral spine over the adjacent segments: a 3D finite element study. J Orthop Surg Res. 2020;15(1):132.PubMedPubMedCentral

Roberts S. Disc morphology in health and disease. Biochem Soc Trans. 2002;30(Pt 6):864–9.PubMed

10.

Desmoulin GT, Pradhan V, Milner TE. Mechanical aspects of intervertebral disc injury and implications on biomechanics. Spine. 2020;45(8):E457-e464.PubMed

11.

Kos N, Gradisnik L, Velnar T. A brief review of the degenerative intervertebral disc disease. Med Arch (Sarajevo, Bosnia and Herzegovina). 2019;73(6):421–4.

12.

Diwan AD, Melrose J. Intervertebral disc degeneration and how it leads to low back pain. JOR spine. 2023;6(1):e1231.PubMed

13.

Lawson L, Harfe BD. Notochord to nucleus pulposus transition. Curr Osteoporos Rep. 2015;13(5):336–41.PubMed

14.

Zhang S, Liu W, Chen S, Wang B, Wang P, Hu B, et al. Extracellular matrix in intervertebral disc: basic and translational implications. Cell Tissue Res. 2022;390(1):1–22.PubMed

15.

Kibble MJ, Domingos M, Hoyland JA, Richardson SM. Importance of matrix cues on intervertebral disc development, degeneration, and regeneration. Int J Mol Sci. 2022;23(13).

16.

Kirnaz S, Capadona C, Lintz M, Kim B, Yerden R, Goldberg JL, et al. Pathomechanism and biomechanics of degenerative disc disease: features of healthy and degenerated discs. Int J Spine Surg. 2021;15(s1):10–25.PubMedPubMedCentral

17.

Wang WJ, Yu XH, Wang C, Yang W, He WS, Zhang SJ, et al. MMPs and ADAMTSs in intervertebral disc degeneration. Clin Chim Acta. 2015;448:238–46.PubMed

18.

Kim NK, Shin DA, Han IB, Yoo EH, Kim SH, Chung SS. The association of aggrecan gene polymorphism with the risk of intervertebral disc degeneration. Acta Neurochir. 2011;153(1):129–33.PubMed

19.

Wei Q, Zhang X, Zhou C, Ren Q, Zhang Y. Roles of large aggregating proteoglycans in human intervertebral disc degeneration. Connect Tissue Res. 2019;60(3):209–18.PubMed

20.

• Francisco V, Pino J, González-Gay M, Lago F, Karppinen J, Tervonen O, et al. A new immunometabolic perspective of intervertebral disc degeneration. Nat Rev Rheumatol. 2022;18(1):47–60. This article provides a general introduction to current immunotherapy for intervertebral disc degeneration.PubMed

21.

Hadjipavlou AG, Tzermiadianos MN, Bogduk N, Zindrick MR. The pathophysiology of disc degeneration: a critical review. J Bone Joint Surg Br. 2008;90(10):1261–70.PubMed

22.

Vergroesen PP, Kingma I, Emanuel KS, Hoogendoorn RJ, Welting TJ, Royen BJ, et al. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthr Cartil. 2015;23(7):1057–70.

23.

Boxberger JI, Sen S, Yerramalli CS, Elliott DM. Nucleus pulposus glycosaminoglycan content is correlated with axial mechanics in rat lumbar motion segments. J Orthop Res. 2006;24(9):1906–15.PubMed

24.

Matsushima N, Miyashita H, Kretsinger RH. Sequence features, structure, ligand interaction, and diseases in small leucine rich repeat proteoglycans. J Cell Commun Signal. 2021;15(4):519–31.PubMedPubMedCentral

25.

Vergari C, Mansfield J, Meakin JR, Winlove PC. Lamellar and fibre bundle mechanics of the annulus fibrosus in bovine intervertebral disc. Acta Biomater. 2016;37:14–20.PubMed

26.

Sivan SS, Hayes AJ, Wachtel E, Caterson B, Merkher Y, Maroudas A, et al. Biochemical composition and turnover of the extracellular matrix of the normal and degenerate intervertebral disc. Eur Spine J. 2014;23(Suppl 3):S344-353.PubMed

27.

Adams MA, McNally DS, Dolan P. ‘Stress’ distributions inside intervertebral discs. The effects of age and degeneration. J Bone Joint Surg Br. 1996;78(6):965–72.PubMed

28.

Roberts S, Evans H, Trivedi J, Menage J. Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am. 2006;88(Suppl 2):10–4.PubMed

29.

• Kamali A, Ziadlou R, Lang G, Pfannkuche J, Cui S, Li Z, et al. Small molecule-based treatment approaches for intervertebral disc degeneration: current options and future directions. Theranostics. 2021;11(1):27–47. This article provides a comprehensive introduction of various treatments of small molecule to intervertebral disc degeneration.PubMedPubMedCentral

30.

Zehra U, Tryfonidou M, Iatridis JC, Illien-Jünger S, Mwale F, Samartzis D. Mechanisms and clinical implications of intervertebral disc calcification. Nat Rev Rheumatol. 2022;18(6):352–62.PubMedPubMedCentral

31.

• Wang Y, Kang J, Guo X, Zhu D, Liu M, Yang L, et al. Intervertebral disc degeneration models for pathophysiology and regenerative therapy -benefits and limitations. J Investig Surg. 2022;35(4):935–52. This article introduces different models to research intervertebral disc degeneration.

32.

Zhao R, Liu W, Xia T, Yang L. Disordered mechanical stress and tissue engineering therapies in intervertebral disc degeneration. Polymers. 2019;11(7).

33.

Wang F, Cai F, Shi R, Wang XH, Wu XT. Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthr Cartil. 2016;24(3):398–408.

34.

Kiraz M, Demir E. Relationship of lumbar disc degeneration with hemoglobin value and smoking. Neurochirurgie. 2020;66(5):373–7.PubMed

35.

Gilligan CJ, Cohen SP, Fischetti VA, Hirsch JA, Czaplewski LG. Chronic low back pain, bacterial infection and treatment with antibiotics. Spine J. 2021;21(6):903–14.PubMed

36.

Ravichandran D, Pillai J, Krishnamurthy K. Genetics of intervertebral disc disease: a review. Clin Anat (New York, NY). 2022;35(1):116–20.

37.

Roh EJ, Darai A, Kyung JW, Choi H, Kwon SY, Bhujel B, et al. Genetic therapy for intervertebral disc degeneration. Int J Mol Sci. 2021;22(4).

38.

Ou-Yang DC, Kleck CJ, Ackert-Bicknell CL. Genetics of intervertebral disc degeneration. Curr Osteoporos Rep. 2023;21(1):56–64.PubMed

39.

Cannata F, Vadalà G, Ambrosio L, Fallucca S, Napoli N, Papalia R, et al. Intervertebral disc degeneration: a focus on obesity and type 2 diabetes. Diabetes Metab Res Rev. 2020;36(1):e3224.PubMed

40.

Pabalan N, Tabangay L, Jarjanazi H, Vieira LA, Dos Santos AA, Barbosa CP, et al. Association between the FokI and ApaI polymorphisms in the vitamin D receptor gene and intervertebral disc degeneration: a systematic review and meta-analysis. Genet Test Mol Biomarkers. 2017;21(1):24–32.PubMed

41.

Nv A, Rajasekaran S, Ks SVA, Kanna RM, Shetty AP. Factors that influence neurological deficit and recovery in lumbar disc prolapse-a narrative review. Int Orthop. 2019;43(4):947–55.PubMed

42.

Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. FEBS J. 2018;285(16):2944–71.PubMedPubMedCentral

43.

Mikolajczyk TP, Szczepaniak P, Vidler F, Maffia P, Graham GJ, Guzik TJ. Role of inflammatory chemokines in hypertension. Pharmacol Ther. 2021;223:107799.PubMed

44.

Palomino DC, Marti LC. Chemokines and immunity. Einstein (Sao Paulo, Brazil). 2015;13(3):469–73.PubMed

45.

Onuffer JJ, Horuk R. Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol Sci. 2002;23(10):459–67.PubMed

46.

Miller MC, Mayo KH. Chemokines from a structural perspective. Int J Mol Sci. 2017;18(10).

47.

Navone SE, Peroglio M, Guarnaccia L, Beretta M, Grad S, Paroni M, et al. Mechanical loading of intervertebral disc modulates microglia proliferation, activation, and chemotaxis. Osteoarthr Cartil. 2018;26(7):978–87.

48.

Kokubo Y, Uchida K, Kobayashi S, Yayama T, Sato R, Nakajima H, et al. Herniated and spondylotic intervertebral discs of the human cervical spine: histological and immunohistological findings in 500 en bloc surgical samples. Laboratory investigation. J Neurosurg Spine. 2008;9(3):285–95.PubMed

49.

Hesselgesser J, Halks-Miller M, DelVecchio V, Peiper SC, Hoxie J, Kolson DL, et al. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr Biol. 1997;7(2):112–21.PubMed

50.

Zhang Y, Zhang H, Lin S, Chen X, Yao Y, Mao X, et al. SDF-1/CXCR7 Chemokine signaling is induced in the peri-infarct regions in patients with ischemic stroke. Aging Dis. 2018;9(2):287–95.PubMedPubMedCentral

51.

Pozzobon T, Goldoni G, Viola A, Molon B. CXCR4 signaling in health and disease. Immunol Lett. 2016;177:6–15.PubMed

52.

Bouyssou JM, Ghobrial IM, Roccaro AM. Targeting SDF-1 in multiple myeloma tumor microenvironment. Cancer Lett. 2016;380(1):315–8.PubMed

53.

Teixidó J, Martínez-Moreno M, Díaz-Martínez M, Sevilla-Movilla S. The good and bad faces of the CXCR4 chemokine receptor. Int J Biochem Cell Biol. 2018;95:121–31.PubMed

54.

Er ZJ, Yin CF, Wang WJ, Chen XJ. Serum CXCL12/SDF-1 level is positively related with lumbar intervertebral disc degeneration and clinical severity. Innate Immun. 2020;26(5):341–50.PubMed

55.

Peng B, Chen J, Kuang Z, Li D, Pang X, Zhang X. Expression and role of connective tissue growth factor in painful disc fibrosis and degeneration. Spine. 2009;34(5):E178-182.PubMed

56.

Zhang H, Wang P, Zhang X, Zhao W, Ren H, Hu Z. SDF1/CXCR7 signaling axis participates in angiogenesis in degenerated discs via the PI3K/AKT pathway. DNA Cell Biol. 2019;38(5):457–67.PubMed

57.

Zendedel A, Nobakht M, Bakhtiyari M, Beyer C, Kipp M, Baazm M, et al. Stromal cell-derived factor-1 alpha (SDF-1α) improves neural recovery after spinal cord contusion in rats. Brain Res. 2012;1473:214–26.PubMed

58.

Zhong H, Zhou Z, Guo L, Liu F, Zheng B, Bi S, et al. The miR-623/CXCL12 axis inhibits LPS-induced nucleus pulposus cell apoptosis and senescence. Mech Ageing Dev. 2021;194:111417.PubMed

59.

Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, et al. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine. 2005;30(21):2379–87.PubMed

60.

Leung VY, Aladin DM, Lv F, Tam V, Sun Y, Lau RY, et al. Mesenchymal stem cells reduce intervertebral disc fibrosis and facilitate repair. Stem Cells (Dayton, Ohio). 2014;32(8):2164–77.PubMed

61.

Bhujel B, Shin HE, Choi DJ, Han I. Mesenchymal stem cell-derived exosomes and intervertebral disc regeneration: review. Int J Mol Sci. 2022;23(13).

62.

He Z, Jia M, Yu Y, Yuan C, Wang J. Roles of SDF-1/CXCR4 axis in cartilage endplate stem cells mediated promotion of nucleus pulposus cells proliferation. Biochem Biophys Res Commun. 2018;506(1):94–101.PubMed

63.

Wei JN, CF, Wu XT, Wang F, Hong X, Wang YT, et al. Efficacy of CXCR4 over-expressed mesenchymal stem cells in the treatment of intervertebral disc degeneration. J Southeast Univ. 2015;34(4):541–546.

64.

Li P, Deng J, Wei X, Jayasuriya CT, Zhou J, Chen Q, et al. Blockade of hypoxia-induced CXCR4 with AMD3100 inhibits production of OA-associated catabolic mediators IL-1β and MMP-13. Mol Med Rep. 2016;14(2):1475–82.PubMedPubMedCentral

65.

Gao ZY, Yu LL, Shi BX, Dong ZL, Sun YJ, Ma HS. T140 inhibits apoptosis and promotes proliferation and matrix formation through the SDF-1/CXC receptor-4 signaling pathway in endplate chondrocytes of the rat intervertebral discs. World Neurosurg. 2020;133:e165–72.PubMed

66.

Liu Q, Li A, Tian Y, Wu JD, Liu Y, Li T, et al. The CXCL8-CXCR1/2 pathways in cancer. Cytokine Growth Factor Rev. 2016;31:61–71.PubMedPubMedCentral

67.

Zhu H, Chen G, Wang Y, Lin X, Zhou J, Wang Z, et al. Dimethyl fumarate protects nucleus pulposus cells from inflammation and oxidative stress and delays the intervertebral disc degeneration. Exp Ther Med. 2020;20(6):269.PubMedPubMedCentral

68.

Pedersen LM, Schistad E, Jacobsen LM, Røe C, Gjerstad J. Serum levels of the pro-inflammatory interleukins 6 (IL-6) and -8 (IL-8) in patients with lumbar radicular pain due to disc herniation: A 12-month prospective study. Brain Behav Immun. 2015;46:132–6.PubMed

69.

Lopes AH, Brandolini L, Aramini A, Bianchini G, Silva RL, Zaperlon AC, et al. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain. Pharmacol Res. 2016;103:69–79.PubMed

70.

Krock E, Millecamps M, Anderson KM, Srivastava A, Reihsen TE, Hari P, et al. Interleukin-8 as a therapeutic target for chronic low back pain: upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model. EBioMedicine. 2019;43:487–500.PubMedPubMedCentral

71.

Gawri R, Rosenzweig DH, Krock E, Ouellet JA, Stone LS, Quinn TM, et al. High mechanical strain of primary intervertebral disc cells promotes secretion of inflammatory factors associated with disc degeneration and pain. Arthritis Res Ther. 2014;16(1):R21.PubMedPubMedCentral

72.

Phillips KL, Cullen K, Chiverton N, Michael AL, Cole AA, Breakwell LM, et al. Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes. Osteoarthr Cartil. 2015;23(7):1165–77.

73.

Shi Z, Shen J, Qiu J, Zhao Q, Hua K, Wang H. CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors. Theranostics. 2021;11(15):7175–87.PubMedPubMedCentral

74.

Lahrtz F, Piali L, Nadal D, Pfister HW, Spanaus KS, Baggiolini M, et al. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol. 1997;27(10):2484–9.PubMed

75.

Zhang X, Fan L, Wu J, Xu H, Leung WY, Fu K, et al. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization. J Hepatol. 2019;71(1):163–74.PubMed

76.

Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I, et al. Graves’ disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101388.PubMed

77.

Hegewald AA, Neumann K, Kalwitz G, Freymann U, Endres M, Schmieder K, et al. The chemokines CXCL10 and XCL1 recruit human annulus fibrosus cells. Spine. 2012;37(2):101–7.PubMed

78.

Kawaguchi S, Yamashita T, Katahira G, Yokozawa H, Torigoe T, Sato N. Chemokine profile of herniated intervertebral discs infiltrated with monocytes and macrophages. Spine. 2002;27(14):1511–6.PubMed

79.

Xia P, Gao X, Li F, Shao L, Sun Y. Down-regulation of microRNA-30d alleviates intervertebral disc degeneration through the promotion of FOXO3 and suppression of CXCL10. Calcif Tissue Int. 2021;108(2):252–64.PubMed

80.

Yang JE, Zhao KH, Qu Y, Zou YC. Increased serum CXCL10 levels are associated with clinical severity and radiographic progression in patients with lumbar disc degeneration. Clin Chim Acta. 2022;525:15–22.PubMed

81.

Ju YY, Jiang M, Xu F, Wang D, Ding B, Ma LJ, et al. CXCL10 and CXCR3 in the trigeminal ganglion contribute to trigeminal neuropathic pain in mice. J Pain Res. 2021;14:41–51.PubMedPubMedCentral

82.

Kong YF, Sha WL, Wu XB, Zhao LX, Ma LJ, Gao YJ. CXCL10/CXCR3 Signaling in the DRG exacerbates neuropathic pain in mice. Neurosci Bull. 2021;37(3):339–52.PubMed

83.

Mordillo-Mateos L, Sánchez-Ramos A, Coperchini F, Bustos-Guadamillas I, Alonso-Bonilla C, Vargas-Baquero E, et al. Development of chronic pain in males with traumatic spinal cord injury: role of circulating levels of the chemokines CCL2 and CXCL10 in subacute stage. Spinal Cord. 2019;57(11):953–9.PubMed

84.

Gruber HE, Marrero E, Ingram JA, Hoelscher GL, Hanley EN Jr. The chemokine, CXCL16, and its receptor, CXCR6, are constitutively expressed in human annulus fibrosus and expression of CXCL16 is up-regulated by exposure to IL-1ß in vitro. Biotech Histochem. 2017;92(1):7–14.PubMed

85.

Haller H, Bertram A, Nadrowitz F, Menne J. Monocyte chemoattractant protein-1 and the kidney. Curr Opin Nephrol Hypertens. 2016;25(1):42–9.PubMed

86.

Yan J, Zuo G, Sherchan P, Huang L, Ocak U, Xu W, et al. CCR1 activation promotes neuroinflammation through CCR1/TPR1/ERK1/2 signaling pathway after intracerebral hemorrhage in mice. Neurotherapeutics. 2020;17(3):1170–83.PubMedPubMedCentral

87.

Zhang K, Luo J. Role of MCP-1 and CCR2 in alcohol neurotoxicity. Pharmacol Res. 2019;139:360–6.ADSPubMed

88.

Cai WT, Guan P, Lin MX, Fu B, Wu B. Sirt1 suppresses MCP-1 production during the intervertebral disc degeneration by inactivating AP-1 subunits c-Fos/c-Jun. Eur Rev Med Pharmacol Sci. 2020;24(11):5895–904.PubMed

89.

Nakawaki M, Uchida K, Miyagi M, Inoue G, Kawakubo A, Kuroda A, et al. Sequential CCL2 expression profile after disc injury in mice. J Orthop Res. 2020;38(4):895–901.PubMed

90.

Zhu X, Cao S, Zhu MD, Liu JQ, Chen JJ, Gao YJ. Contribution of chemokine CCL2/CCR2 signaling in the dorsal root ganglion and spinal cord to the maintenance of neuropathic pain in a rat model of lumbar disc herniation. J Pain. 2014;15(5):516–26.PubMed

91.

Ou X, Ying J, Bai X, Wang C, Ruan D. Activation of SIRT1 promotes cartilage differentiation and reduces apoptosis of nucleus pulposus mesenchymal stem cells via the MCP1/CCR2 axis in subjects with intervertebral disc degeneration. Int J Mol Med. 2020;46(3):1074–84.PubMedPubMedCentral

92.

Aldinucci D, Borghese C, Casagrande N. The CCL5/CCR5 axis in cancer progression. Cancers. 2020;12(7).

93.

Zeng Z, Lan T, Wei Y, Wei X. CCL5/CCR5 axis in human diseases and related treatments. Genes Dis. 2022;9(1):12–27.PubMed

94.

Gruber HE, Hoelscher GL, Ingram JA, Bethea S, Norton HJ, Hanley EN Jr. Production and expression of RANTES (CCL5) by human disc cells and modulation by IL-1-β and TNF-α in 3D culture. Exp Mol Pathol. 2014;96(2):133–8.PubMed

95.

Liu W, Liu D, Zheng J, Shi P, Chou PH, Oh C, et al. Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration. Spine J. 2017;17(5):720–6.PubMedPubMedCentral

96.

Pattappa G, Peroglio M, Sakai D, Mochida J, Benneker LM, Alini M, et al. CCL5/RANTES is a key chemoattractant released by degenerative intervertebral discs in organ culture. Eur Cell Mater. 2014;27:124–36; discussion 136.PubMed

97.

Pattappa G, Johnstone B, Zellner J, Docheva D, Angele P. The importance of physioxia in mesenchymal stem cell chondrogenesis and the mechanisms controlling its response. Int J Mol Sci. 2019;20(3).

98.

Grad S, Bow C, Karppinen J, Luk KD, Cheung KM, Alini M, et al. Systemic blood plasma CCL5 and CXCL6: potential biomarkers for human lumbar disc degeneration. Eur Cell Mater. 2016;31:1–10.PubMed

99.

Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells (Dayton, Ohio). 2006;24(4):1030–41.PubMed

100.

Kadomoto S, Izumi K, Mizokami A. The CCL20-CCR6 axis in cancer progression. Int J Mol Sci. 2020;21(15).

101.

Zhang Y, Liu L, Wang S, Zhao Y, Liu Y, Li J, et al. Production of CCL20 on nucleus pulposus cells recruits IL-17-producing cells to degenerated IVD tissues in rat models. J Mol Histol. 2016;47(1):81–9.PubMed

102.

Hiyama A, Suyama K, Sakai D, Tanaka M, Watanabe M. Correlational analysis of chemokine and inflammatory cytokine expression in the intervertebral disc and blood in patients with lumbar disc disease. J Orthop Res. 2022;40(5):1213–22.PubMed

103.

Stich S, Möller A, Cabraja M, Krüger JP, Hondke S, Endres M, et al. Chemokine CCL25 induces migration and extracellular matrix production of anulus fibrosus-derived cells. Int J Mol Sci. 2018;19(8).

104.

Korbecki J, Simińska D, Kojder K, Grochans S, Gutowska I, Chlubek D, et al. Fractalkine/CX3CL1 in neoplastic processes. Int J Mol Sci. 2020;21(10).

105.

Subbarayan MS, Joly-Amado A, Bickford PC, Nash KR. CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases. Pharmacol Ther. 2022;231:107989.PubMed

106.

Mecca C, Giambanco I, Donato R, Arcuri C. Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes. Int J Mol Sci. 2018;19(1).

107.

von Vietinghoff S, Kurts C. Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease. Cell Tissue Res. 2021;385(2):335–44.

108.

Choi J, Selmi C, Leung PS, Kenny TP, Roskams T, Gershwin ME. Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis. Expert Rev Clin Immunol. 2016;12(6):661–72.PubMedPubMedCentral

109.

Ni Y, Zhuge F, Ni L, Nagata N, Yamashita T, Mukaida N, et al. CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status. Metab Clin Exp. 2022;136:155272.PubMed

110.

Oh IS, Suh DW, Park SR, Ha KY. Fractalkine receptor chemokine (CX3CR1) influences on cervical and lumbar disc herniation. Indian J Orthop. 2015;49(2):239–44.PubMedPubMedCentral

111.

Qingguang Q, Zujiang C, Weimin F, Junhua LI, Liqing L, Yikai LI. Hyperpolarization-activated cyclic nucleotide-gated 2 contributes to electroacupuncture analgesia on lumbar disc herniation-induced radicular pain through activation of microglia in spinal dorsal horn. J Tradit Chin Med. 2022;42(3):372–8.PubMed

112.

Virk SS, Niedermeier S, Yu E, Khan SN. Adjacent segment disease. Orthopedics. 2014;37(8):547–55.PubMed

113.

Franco D, Largoza G, Montenegro TS, Gonzalez GA, Hines K, Harrop J. Lumbar total disc replacement: current usage. Neurosurg Clin N Am. 2021;32(4):511–9.PubMed

114.

Othman YA, Verma R, Qureshi SA. Artificial disc replacement in spine surgery. Ann Transl Med. 2019;7(Suppl 5):S170.PubMedPubMedCentral

115.

Kamatani T, Hagizawa H, Yarimitsu S, Morioka M, Koyamatsu S, Sugimoto M, et al. Human iPS cell-derived cartilaginous tissue spatially and functionally replaces nucleus pulposus. Biomaterials. 2022;284:121491.PubMed

116.

Frapin L, Clouet J, Delplace V, Fusellier M, Guicheux J, Le Visage C. Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors. Adv Drug Deliv Rev. 2019;149–150:49–71.PubMed

117.

Miyabe Y, Miyabe C, Iwai Y, Luster AD. Targeting the chemokine system in rheumatoid arthritis and vasculitis. JMA journal. 2020;3(3):182–92.PubMedPubMedCentral

118.

Xu M, Wang Y, Xia R, Wei Y, Wei X. Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting. Cell Prolif. 2021;54(10):e13115.PubMedPubMedCentral

119.

Wang J, Tian Y, Phillips KL, Chiverton N, Haddock G, Bunning RA, et al. Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Arthritis Rheum. 2013;65(3):832–42.PubMedPubMedCentral

120.

Chou PH, Chee A, Shi P, Lin CL, Zhao Y, Zhang L, et al. Small molecule antagonist of C-C chemokine receptor 1 (CCR1) reduces disc inflammation in the rabbit model. Spine J. 2020;20(12):2025–36.PubMed

121.

Henriksson HB, Svala E, Skioldebrand E, Lindahl A, Brisby H. Support of concept that migrating progenitor cells from stem cell niches contribute to normal regeneration of the adult mammal intervertebral disc: a descriptive study in the New Zealand white rabbit. Spine. 2012;37(9):722–32.PubMed

122.

Vanden Berg-Foels WS. In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment. Tissue Eng Part B Rev. 2014;20(1):28–39.PubMed

123.

Mauney J, Olsen BR, Volloch V. Matrix remodeling as stem cell recruitment event: a novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix. Matrix Biol. 2010;29(8):657–63.PubMedPubMedCentral

124.

Illien-Jünger S, Pattappa G, Peroglio M, Benneker LM, Stoddart MJ, Sakai D, et al. Homing of mesenchymal stem cells in induced degenerative intervertebral discs in a whole organ culture system. Spine. 2012;37(22):1865–73.PubMed

125.

Purcell BP, Elser JA, Mu A, Margulies KB, Burdick JA. Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials. 2012;33(31):7849–57.PubMedPubMedCentral

126.

Henry N, Clouet J, Le Bideau J, Le Visage C, Guicheux J. Innovative strategies for intervertebral disc regenerative medicine: from cell therapies to multiscale delivery systems. Biotechnol Adv. 2018;36(1):281–94.PubMed

127.

Blanquer SB, Grijpma DW, Poot AA. Delivery systems for the treatment of degenerated intervertebral discs. Adv Drug Deliv Rev. 2015;84:172–87.PubMed

128.

Flégeau K, Pace R, Gautier H, Rethore G, Guicheux J, Le Visage C, et al. Toward the development of biomimetic injectable and macroporous biohydrogels for regenerative medicine. Adv Coll Interface Sci. 2017;247:589–609.

129.

Muylaert DE, van Almen GC, Talacua H, Fledderus JO, Kluin J, Hendrikse SI, et al. Early in-situ cellularization of a supramolecular vascular graft is modified by synthetic stromal cell-derived factor-1α derived peptides. Biomaterials. 2016;76:187–95.PubMed

130.

Zamproni LN, Mundim MV, Porcionatto MA. des Rieux A: Injection of SDF-1 loaded nanoparticles following traumatic brain injury stimulates neural stem cell recruitment. Int J Pharm. 2017;519(1–2):323–31.PubMed

131.

Dutta D, Hickey K, Salifu M, Fauer C, Willingham C, Stabenfeldt SE. Spatiotemporal presentation of exogenous SDF-1 with PLGA nanoparticles modulates SDF-1/CXCR4 signaling axis in the rodent cortex. Biomater Sci. 2017;5(8):1640–51.PubMedPubMedCentral

132.

Pereira CL, Gonçalves RM, Peroglio M, Pattappa G, D’Este M, Eglin D, et al. The effect of hyaluronan-based delivery of stromal cell-derived factor-1 on the recruitment of MSCs in degenerating intervertebral discs. Biomaterials. 2014;35(28):8144–53.PubMed

133.

Frapin L, Clouet J, Chédeville C, Moraru C, Samarut E, Henry N, et al. Controlled release of biological factors for endogenous progenitor cell migration and intervertebral disc extracellular matrix remodelling. Biomaterials. 2020;253:120107.PubMed

Title: Roles of Chemokines in Intervertebral Disk Degeneration
Authors: Pengfei Xue
Yi Wang
Long Lv
Dongming Wang
Yuntao Wang
Publication date: 17-11-2023
Publisher: Springer US
Keywords: Back Pain
Back Pain
Back Pain
Published in: Current Pain and Headache Reports / Issue 3/2024
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI: https://doi.org/10.1007/s11916-023-01188-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Roles of Chemokines in Intervertebral Disk Degeneration

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 3/2024

Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023

Telehealth and Virtual Reality Technologies in Chronic Pain Management: A Narrative Review

Transitional Pain Service: Optimizing Complex Surgical Patients

Unraveling the MSG-Headache Controversy: an Updated Literature Review

Categorizing Sports-Related Concussion Disparities by Key Domains of Social Determinants of Health

Ominous causes of headache